After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Reported value range
Not reported

Accardi Mario Alberto Chief Executive Officer

Transaction date Jun 24, 2026
Public filing date Jun 24, 2026
Filing lag Filed same day

CNTA daily price context

Close on/before transaction
$40.5 Jun 23, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Share Option (right to buy) on Ordinary Shares
Quantity / price
16,875 shares
SEC ownership
Direct
Transaction code
D
Form
4
Filing identifier
0001470831-26-000616
Filing cohort

Transactions in this filing

Showing 7 of 7
Trades
7
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Centessa Pharmaceuticals Plc CNTA Disposition Jun 24, 2026 Not reported
Centessa Pharmaceuticals Plc CNTA Disposition Jun 24, 2026 Not reported
Centessa Pharmaceuticals Plc CNTA Current Disposition Jun 24, 2026 Not reported
Centessa Pharmaceuticals Plc CNTA Disposition Jun 24, 2026 Not reported
Centessa Pharmaceuticals Plc CNTA Disposition Jun 24, 2026 Not reported
Centessa Pharmaceuticals Plc CNTA Disposition Jun 24, 2026 Not reported
Centessa Pharmaceuticals Plc CNTA Disposition Jun 24, 2026 Not reported